Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: A follow-up study of 3,029 patients with primary Raynaud's phenomenon

Rheumatology International

Volumn 32, Issue 10, 2012, Pages 3039-3045

  Pavlov Dolijanovic, Slavica ^a   Damjanov, Nemanja S ^b   Stojanovic, Roksanda M ^b   Vujasinovic Stupar, Nada Z ^b   Stanisavljevic, Dejana M ^b  

^a INSTITUTE OF RHEUMATOLOGY   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Capillaroscopy; Connective tissue disease; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CAPILLAROSCOPY; CHILD; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; NAIL; OUTCOME ASSESSMENT; POLYMYOSITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS;

ADOLESCENT; ADULT; AGED; CAPILLARIES; CHI-SQUARE DISTRIBUTION; CHILD; CONNECTIVE TISSUE DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RAYNAUD DISEASE; RISK ASSESSMENT; RISK FACTORS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; TIME FACTORS; YOUNG ADULT;

EID: 84867901723     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2109-2     Document Type: Article

References (43)

1. Wigley FM (2002) Raynaud's phenomenon. N Engl J Med 347:1001-1008
2. Maricq HR, Weinberg AB, LeRoy EC (1982) Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. J Rheumatol 9:289-291
3. Kallenberg CG, Pastoor GW, Wouda AA (1982) Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 41:382-387
4. Porter JM, Bardana EJ Jr, Baur GM, Wesche DH, Andrasch RH, Rosch J (1976) The clinical significance of Raynaud's syndrome. Surgery 80:756-764
5. Zufferey P, Depairon M, Chamot AM, Monti M (1992) Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma pattern abnormalities: a six-years follow-up study. Clin Rheumatol 11:536-541
6. Spencer-Green G (1998) Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595-600
7. Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud's phenomenon and the role of capillaroscopy. Arthr Rheum 48:3023-3030
8. Maricq HR, Spencer-Green G, LeRoy EC (1976) Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud syndrome and dermatomyositis. Am J Med 61:862-870
9. Maricq HR, LeRoy EC, D'Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthr Rheum 23:183-189
10. Houtman PM, Kallenberg CGM, Wouda AA, The TH (1985) Decreased nailfold capillary density in Raynaud phenomenon: a reflection of immunologically mediated local and systemic vascular disease. Ann Rheum Dis 44:603-609
11. Meli M, Gityelmann G, Koppensteiner R, Amann-Vesti BR (2006) Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon. Clin Rheumatol 25:153-158
12. LeRoy EC, Medsger TA Jr (1992) Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485-488
13. Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthr Rheum 24:1159-1164
14. Damjanov N, Pavlov S, Radosavljevic V, Ostojic P, Curcic A (1998) Prognostic significance of capillaroscopic findings in subjects with Raynaud phenomenon. Acta Rheumatol Belgradensia 28:12-17
15. LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 15:202-205
16. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271-1277
17. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315-324
18. Alarcon-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328-334
19. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403-407
20. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-Europe Consensus Group. Ann Rheum Dis 61:554-558
21. Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheum 17:615-620
22. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthr Rheum 42:1309-1311
23. Campbell G (1994) Advances in statistical methodology for the evaluation of diagnosis and laboratory test. Stat Med 13:499-508
24. Cervini C, Grassi W (1996) Raynaud's phenomenon. Rheumatol Eur 25:111-113
25. Maricq HR, Weinrich MC, Keli JE, LeRoy EC (1986) Prevalence of Raynaud's phenomenon in the general population. J Chron Dis 39:423-427
26. Harper FE, Maricq HR, Turner RE, Lidman RW, LeRoy EC (1982) A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med 72:883-888
27. Nagy Z, Czirják L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease. JEADV 18:62-68
28. Kabasakal Y, Elvins DM, Ring EF, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507-512
29. Furtado RNV, Pucinelli ML, Cristo VV, Andrade LE, Sato EI (2002) Scleroderma like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SEL patients. Lupus 11:35-41
30. Nakano M, Ohuchi Y, Hasegawa H, Kuroda T, Ito S, Gejyo F (2000) Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 27:1403-1407
31. Fritzler MJ, Kinsella TD (1980) The CREST syndrome: a distinct serologic entirety with anticentromere antibodies. Am J Med 69:520-526
32. Ferri C, Bernini L, Cecchetti R et al (1991) Cutaneous and serologic subset of systemic sclerosis. J Rheumatol 18:1826-1832
33. Sarkozi J, Bookman AM, Lee P, Keystone EC, Fritzler MJ (1987) Significance of anticentromere antibody in idiopathic Raynaud's syndrome. Am J Med 83:893-898
34. Lambova SN, Müller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263-1271
35. Ingegnolli F, Zeni S, Meani L, Soldi A, Lurati A, Fantini F (2005) Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 11:295-298
36. Bongard O, Bounameaux H, Miescher PA, deMoerloose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4:142-144
37. Jouanny P, Schmidt C, Feldmann L, Schmitt J (1994) Focus on a quick reading of nailfold capillaroscopy. J Mal Vasc 19:206-209
38. Fitzgerald O, Hess EV, O'Connor GT, Spencer-Green G (1988) Prospective study of the evolution of Raynaud's phenomenon. Am J Med 84:718-726
39. Luggen M, Belhorn L, Evans T, Fitzgerald O, Spencer-Green G (1995) The evolution of Raynaud's phenomenon: a longterm prospective study. J Rheumatol 22:2226-2232
40. Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM (1999) Microvascular abnormalities in Sjögren's syndrome: nailfold capillaroscopy. Rheumatology 38:826-830
41. Redisch W (1970) Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 29:244-253
42. Zimmerman C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS (1998) The concurrence of rheumatoid arthritis and limited systemic sclerosis. Clinical and serological characteristics of an overlap syndrome. Arthr Rheum 41:1938-1945
43. Ohtsuka T, Tamura T, Yamakage A, Yamazaki S (1998) The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol 139:622-629